A novel cardiometabolic therapeutic prospect Cardiometabolic diseases as diabetes mellitus, heart disease, overweight, obesity, hypertension, hyperlipidemia and its multiple macro and microvascular complications (ischemic cardiomyopathy, stroke, chronic kidney disease, retinopathy, peripheral neuropathy, etc.) are conditions closely related to each other and constitute at present time the leading cause of morbility, disability and death in the world [28]
They also send valuable telemetry including current, voltage, cell balance, temperature, RPM and more to your compatible transmitter in real time
Chan, L
[DOI] [PMC free article] [PubMed] [Google Scholar] del Marmol V., Solano F., Sels A., Huez G., Libert A., Lejeune F., Ghanem G
"When FDA-approved drugs are available, outsourcing facilities cannot lawfully compound using bulk drug substances unless there is a clear clinical need," FDA Commissioner Marty Makary stated in the agency's announcement